May, 2021

article thumbnail

Study finds Germany trails Spain and the US in digital health

pharmaphorum

Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The three-country poll found that Spain is way out in front, with over half of people asked responding that digital is already playing a major role in the networking of healthcare facilities, diagnosing illnesses and telemedicine.

article thumbnail

Biden Backs Suspending Patents on Covid Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

Vaccines 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CVS Health broadens commitment to improving clinical trial infrastructure

Outsourcing Pharma

The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.

138
138
article thumbnail

Janssen seeks EU approval for first CAR-T therapy cilta-cel

Pharma Times

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma

146
146
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

Terrassa (Barcelona). Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote the presence and distribution of Telstar branded Life Sciences service & product solutions in the region, particularly

article thumbnail

New patent expiration for Osi Pharms drug TARCEVA

Drug Patent Watch

Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Osi Pharms drug TARCEVA appeared first on DrugPatentWatch - Make Better Decisions.

98

More Trending

article thumbnail

After a Decade Without Executions, South Carolina’s Solution: Bring Out the Firing Squad

NY Times

State lawmakers have voted to add the firing squad as an alternative to the electric chair or lethal injection, with the drugs used for capital punishment in short supply.

105
105
article thumbnail

Explore vital drug delivery innovations at online event

Outsourcing Pharma

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

111
111
article thumbnail

AZ' Tagrisso first to win MHRA approval under Project Orbis

Pharma Times

Decision brings the innovative treatment to early-stage lung cancer patients, helping to address unmet need in this setting

129
129
article thumbnail

Virtual Reality – FDA and AdComms

Eye on FDA

Vaccination has been robust. Cities are opening up. Plans are underway for back-to-school. Travel is robust. Offices are cautiously re-opening. There are multiple hallmarks that, whatever the consequences, we are going back to normal. The age of COVID-19 will likely continue, but with the emergence of a significant proportion of the population with vaccines pumped into them, we headed back on almost every level.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New patent for Teva Pharm drug ARMONAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

BioNTech to set up mRNA manufacturing site in Singapore

pharmaphorum

BioNTech has said it plans to set up a regional base and new manufacturing site in Singapore so that the biotech can keep pace with demand for its mRNA-based coronavirus vaccine and pipeline products in other disease areas. The German firm said the production facility will be able to produce several hundred million doses of mRNA-based vaccine, depending on the requirements of the specific vaccine.

Vaccines 118
article thumbnail

W.H.O. Approves China’s Sinopharm Vaccine for Emergency Use

NY Times

Sinopharm is the first Chinese shot to be classified as safe and effective by the World Health Organization, allowing the vaccine to be more widely distributed to poor and middle-income nations.

article thumbnail

Artificial intelligence can elevate pharma manufacturing

Outsourcing Pharma

According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.

107
107
article thumbnail

Janssen inks inflammatory disease collaboration with Mestag Therapeutics

Pharma Times

Collaboration will utilise Mestag’s specialist fibroblast subpopulation biology platform to identify novel therapeutic targets

123
123
article thumbnail

Once in a Lifetime: Customer Experience at Momentous Moments

Pharma Marketing Network

Some moments in life are profoundly important. Perhaps you’ve saved carefully for years to take your family on a special vacation. Or perhaps you’ve just been given a life-changing diagnosis that’s left you in a state of shock. Whether positive or negative, in a moment that important, you’re living in an altered state. Things might seem overwhelming, with the world moving too fast for you to understand what’s going on; or you may freeze, and it may feel like reality has slowed to a crawl.

87
article thumbnail

New patent for Indivior Inc drug SUBLOCADE

Drug Patent Watch

Annual Drug Patent Expirations for SUBLOCADE Sublocade is a drug marketed by Indivior Inc and is included in one NDA. It is available from one supplier. There are ten patents…. The post New patent for Indivior Inc drug SUBLOCADE appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

pharmaphorum

A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty shot. . The Pharmacovigilance Risk Assessment Committee (PRAC) says it is aware of cases of myocarditis and pericarditis – inflammation of the heart muscle and membrane around the heart – with the vaccine.

Vaccines 117
article thumbnail

Taking ‘Extraordinary Measures,’ Biden Backs Suspending Patents on Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

article thumbnail

Reify, SubjectWell partner to elevate trial recruitment

Outsourcing Pharma

The two tech-focused firms are joining forces to work on technology solutions aimed at improving patient recruitment and enrollment for various studies.

104
104
article thumbnail

Researchers find CD38-targeting drugs may show promise against prostate cancer

Pharma Times

Researchers are initiating clinical trials to evaluate whether targeting the CD38 pathway can provide benefit for people with prostate cancer

114
114
article thumbnail

DarshanTalks: How To Build a Trusted Workforce – May 14, 2021

Pharma Marketing Network

[link]. The post DarshanTalks: How To Build a Trusted Workforce</br> – May 14, 2021 appeared first on Pharma Marketing Network.

96
article thumbnail

New patent for Kala Pharms drug EYSUVIS

Drug Patent Watch

Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eleven patents protecting this drug. EYSUVIS drug…. The post New patent for Kala Pharms drug EYSUVIS appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

Coronavirus won’t be circulating in UK by August, says outgoing vaccine chief Clive Dix

pharmaphorum

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. Dix led the programme from December until he stepped down last week and told the Daily Telegraph that the UK’s vaccination campaign should be enough to protect from the virus and its known variants by the summer.

Vaccines 117
article thumbnail

Pfizer Will Seek Approval to Give Covid Vaccine to Children

NY Times

The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in adults.

article thumbnail

FDA leader: ‘stockpiling’ could transform clinical trial system

Outsourcing Pharma

In this third part of a series on the state of clinical research, the acting FDA commissioner talks about possible pathways to improving the infrastructure.

97
article thumbnail

EMA, MHRA to review Vertex' Kaftrio for children with CF

Pharma Times

If approved, up to 2,000 children with CF would be eligible for treatment with the drug

143
143
article thumbnail

A Look Into Telehealth in 2021 and Beyond

Pharma Marketing Network

According to a stat by Medgadget, “Global Telemedicine Market is valued at USD 27.04 Billion in 2019 and Expected to Reach USD 171.81 Billion by 2026 with a CAGR of 37.2% over the Forecast Period.”. The COVID-19 pandemic seriously accelerated the adoption and implementation of telehealth services, like remote patient monitoring and out-of-office “visits” – a trend that was already on the incline.

article thumbnail

New patent for Genus Lifesciences drug GOPRELTO

Drug Patent Watch

Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from one supplier. There are nine patents…. The post New patent for Genus Lifesciences drug GOPRELTO appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

performance-io adds Jason McKenna as a non-executive director

pharmaphorum

UK-based performance-io has added to its senior team through two promotions and the appointment of STEM Healthcare CEO Jason McKenna as a non-executive director. He will oversee the online performance marketing and digital benchmarking agency’s growth in the US joins Rob Wood and Barrie Brien on performance-io’s non-executive board. McKenna has been with STEM since 2010, founding it in the US and Brazil before taking over the CEO role from co-founder Rob Wood in 2018.

117
117
article thumbnail

Pfizer Seeks Full FDA Approval for Its Covid-19 Vaccine

NY Times

The vaccine has been used under an emergency authorization since December. A decision by the Food and Drug Administration could take months.

article thumbnail

Drug development advancements call for skilled workforce

Outsourcing Pharma

According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes.

article thumbnail

NICE green lights Tremfya to treat active psoriatic arthritis

Pharma Times

Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis

124
124
article thumbnail

DarshanTalks: How To Build a Trusted Workforce – May 14, 2021

Pharma Marketing Network

[link]. The post DarshanTalks: How To Build a Trusted Workforce</br> – May 14, 2021 appeared first on Pharma Marketing Network.

59
article thumbnail

New patent for Bayer Hlthcare drug KYLEENA

Drug Patent Watch

Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent for Bayer Hlthcare drug KYLEENA appeared first on DrugPatentWatch - Make Better Decisions.

95